ArticleMolecular diagnosis & therapy2022

Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate.

Ji Min Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.